{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:01:52Z","timestamp":1791856912457,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1546-0096-12-24","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T01:03:00Z","timestamp":1404867780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America"],"prefix":"10.1186","volume":"12","author":[{"given":"Arzu","family":"Soybilgic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Tesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wagner-Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen B","family":"Onel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"issue":"12","key":"1728_CR1","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C: Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology. 2000, 39 (12): 1383-1389. PubMed PMID: 11136882","journal-title":"Rheumatology"},{"key":"1728_CR2","first-page":"569417","volume":"2011","author":"MK Brabnikova","year":"2011","unstructured":"Brabnikova MK: Secondary osteoporosis in patients with juvenile idiopathic arthritis. J Osteoporos. 2011, 2011: 569417-PubMed PMID: 21403891. Pubmed Central PMCID: 3043287","journal-title":"J Osteoporos"},{"issue":"5","key":"1728_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00002281-200109000-00010","volume":"13","author":"JE McDonagh","year":"2001","unstructured":"McDonagh JE: Osteoporosis in juvenile idiopathic arthritis. Curr Opin Rheumatol. 2001, 13 (5): 399-404. PubMed PMID: 11604595","journal-title":"Curr Opin Rheumatol"},{"key":"1728_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1546-0096-7-16","volume":"7","author":"Y Uziel","year":"2009","unstructured":"Uziel Y, Zifman E, Hashkes PJ: Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review. Pediatr Rheumatol Online J. 2009, 7: 16-PubMed PMID: 19835571. Pubmed Central PMCID: 2768686","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"1728_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00393-007-0174-4","volume":"66","author":"J Roth","year":"2007","unstructured":"Roth J, Bechtold S, Borte G, Dressler F, Girschick H, Borte M: Diagnosis, prophylaxis and therapy of osteoporosis in juvenile idiopathic arthritis: consensus statement of the German Association for Pediatric Rheumatology. Z Rheumatol. 2007, 66 (5): 434-440. PubMed PMID: 17522871. Diagnose, Prophylaxe und Therapie der Osteoporose bei juveniler idiopathischer Arthritis: Konsensusstatement der Gesellschaft fur Kinder- und Jugendrheumatologie","journal-title":"Z Rheumatol"},{"issue":"8","key":"1728_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00431-007-0484-1","volume":"166","author":"J Roth","year":"2007","unstructured":"Roth J, Bechtold S, Borte G, Dressler F, Girschick HJ, Borte M: Osteoporosis in juvenile idiopathic arthritis\u2013a practical approach to diagnosis and therapy. Eur J Pediatr. 2007, 166 (8): 775-784. PubMed PMID: 17436015","journal-title":"Eur J Pediatr"},{"issue":"1","key":"1728_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0961203313511679","volume":"23","author":"S Stagi","year":"2014","unstructured":"Stagi S, Cavalli L, Bertini F, Cerinic MM, Brandi ML, Falcini F: Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS. Lupus. 2014, 23 (1): 57-68. PubMed PMID: 24218395","journal-title":"Lupus"},{"issue":"11","key":"1728_CR8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/art.1780401108","volume":"40","author":"CJ Henderson","year":"1997","unstructured":"Henderson CJ, Cawkwell GD, Specker BL, Sierra RI, Wilmott RW, Campaigne BN, Lowell DL: Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum. 1997, 40 (11): 1967-1975. PubMed PMID: 9365085","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1728_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/acr.20171","volume":"62","author":"AM Huber","year":"2010","unstructured":"Huber AM, Gaboury I, Cabral DA, Lang B, Ni A, Stephure D, Taback S, Dent P, Ellsworth J, LeBlanc C, Saint-Cyr C, Scuccimarri R, Hay J, Lentle B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K, Ward LM, Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium: Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res. 2010, 62 (4): 516-526. PubMed PMID: 20391507","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1728_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/acr.20589","volume":"64","author":"C Rodd","year":"2012","unstructured":"Rodd C, Lang B, Ramsay T, Alos N, Huber AM, Cabral DA, Scuccimarri R, Miettunen PM, Roth J, Atkinson SA, Couch R, Cummings EA, Dent PB, Ellsworth J, Hay J, Houghton K, Jurencak R, Larch\u00e9 M, LeBlanc C, Oen K, Saint-Cyr C, Stein R, Stephure D, Taback S, Lentle B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K: Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res. 2012, 64 (1): 122-131. PubMed PMID: 22213727","journal-title":"Arthritis Care Res"},{"issue":"11","key":"1728_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/acr.20295","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG: American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res. 2010, 62 (11): 1515-1526. PubMed PMID: 20662044","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1728_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/ard.54.1.66","volume":"54","author":"ID Peat","year":"1995","unstructured":"Peat ID, Healy S, Reid DM, Ralston SH: Steroid induced osteoporosis: an opportunity for prevention?. Ann Rheum Dis. 1995, 54 (1): 66-68. PubMed PMID: 7880126. Pubmed Central PMCID: 1005515","journal-title":"Ann Rheum Dis"},{"issue":"7053","key":"1728_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","volume":"313","author":"LJ Walsh","year":"1996","unstructured":"Walsh LJ, Wong CA, Pringle M, Tattersfield AE: Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ. 1996, 313 (7053): 344-346. PubMed PMID: 8760745. Pubmed Central PMCID: 2351752","journal-title":"BMJ"},{"issue":"6","key":"1728_CR14","first-page":"1506","volume":"27","author":"E Soucy","year":"2000","unstructured":"Soucy E, Bellamy N, Adachi JD, Pope JE, Flynn J, Sutton E, Campbell J: A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists. J Rheumatol. 2000, 27 (6): 1506-1512. PubMed PMID: 10852279","journal-title":"J Rheumatol"},{"issue":"9","key":"1728_CR15","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1002\/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J","volume":"43","author":"ML Bianchi","year":"2000","unstructured":"Bianchi ML, Cimaz R, Bardare M, Zulian F, Lepore L, Boncompagni A, Corona F, Luisetto G, Giuntini D, Picco P, Brandi ML, Falcini F: Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum. 2000, 43 (9): 1960-1966. PubMed PMID: 11014345","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1728_CR16","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.bone.2004.07.003","volume":"35","author":"LA DiMeglio","year":"2004","unstructured":"DiMeglio LA, Ford L, McClintock C, Peacock M: Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. Bone. 2004, 35 (5): 1038-1045. PubMed PMID: 15542028","journal-title":"Bone"},{"issue":"14","key":"1728_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998, 339 (14): 947-952. PubMed PMID: 9753709","journal-title":"N Engl J Med"},{"issue":"2","key":"1728_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5045\/br.2013.48.2.99","volume":"48","author":"JM Lee","year":"2013","unstructured":"Lee JM, Kim JE, Bae SH, Hah JO: Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Res. 2013, 48 (2): 99-106. PubMed PMID: 23826578. Pubmed Central PMCID: 3698414","journal-title":"Blood Res"},{"issue":"1-2","key":"1728_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1515\/JPEM.2010.23.1-2.73","volume":"23","author":"S Salehpour","year":"2010","unstructured":"Salehpour S, Tavakkoli S: Cyclic pamidronate therapy in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab. 2010, 23 (1-2): 73-80. PubMed PMID: 20432809","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"1728_CR20","first-page":"362","volume":"41","author":"M Stuart","year":"2002","unstructured":"Stuart M: Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children. Clin Pediatr. 2002, 41 (5): 362-363. PubMed PMID: 12086205","journal-title":"Clin Pediatr"},{"issue":"4","key":"1728_CR21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1515\/jpem-2006-190410","volume":"19","author":"E Unal","year":"2006","unstructured":"Unal E, Abaci A, Bober E, Buyukgebiz A: Efficacy and safety of oral alendronate treatment in children and adolescents with osteoporosis. J Pediatr Endocrinol Metab. 2006, 19 (4): 523-528. PubMed PMID: 16759038","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"1728_CR22","first-page":"1282","volume":"25","author":"A Gough","year":"1998","unstructured":"Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, Nguyen T, Emery P: Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol. 1998, 25 (7): 1282-1289. PubMed PMID: 9676757","journal-title":"J Rheumatol"},{"issue":"4","key":"1728_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/rheumatology\/35.4.309","volume":"35","author":"AA Deodhar","year":"1996","unstructured":"Deodhar AA, Woolf AD: Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol. 1996, 35 (4): 309-322. PubMed PMID: 8624634","journal-title":"Br J Rheumatol"},{"issue":"5","key":"1728_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jaci.2013.08.040","volume":"132","author":"B Buehring","year":"2013","unstructured":"Buehring B, Viswanathan R, Binkley N, Busse W: Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol. 2013, 132 (5): 1019-1030. PubMed PMID: 24176682","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1728_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1521-6942(02)90236-6","volume":"16","author":"R Cimaz","year":"2002","unstructured":"Cimaz R: Osteoporosis in childhood rheumatic diseases: prevention and therapy. Best Pract Res Clin Rheumatol. 2002, 16 (3): 397-409. PubMed PMID: 12387807","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"1728_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00223001090","volume":"67","author":"F Falcini","year":"2000","unstructured":"Falcini F, Bindi G, Ermini M, Galluzzi F, Poggi G, Rossi S, Masi L, Cimaz R, Brandi ML: Comparison of quantitative calcaneal ultrasound and dual energy X-ray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases. Calcif Tissue Int. 2000, 67 (1): 19-23. PubMed PMID: 10908407","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1728_CR27","first-page":"179","volume":"30","author":"F Falcini","year":"2003","unstructured":"Falcini F, Bindi G, Simonini G, Stagi S, Galluzzi F, Masi L, Cimaz R: Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study. J Rheumatol. 2003, 30 (1): 179-184. PubMed PMID: 12508409","journal-title":"J Rheumatol"},{"issue":"5","key":"1728_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00256-002-0476-1","volume":"31","author":"I Lernbass","year":"2002","unstructured":"Lernbass I, Wutzl A, Grisar J, Schett G, Redlich K, Spitzauer S, Grampp S, Imhof H, Peterlik M, Pietschmann P: Quantitative ultrasound in the assessment of bone status of patients suffering from rheumatic diseases. Skeletal Radiol. 2002, 31 (5): 270-276. PubMed PMID: 11981603","journal-title":"Skeletal Radiol"},{"issue":"1","key":"1728_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1203\/01.PDR.0000069845.27657.EB","volume":"54","author":"GI Baroncelli","year":"2003","unstructured":"Baroncelli GI, Federico G, Bertelloni S, Sodini F, De Terlizzi F, Cadossi R, Saggese G: Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. Pediatr Res. 2003, 54 (1): 125-136. PubMed PMID: 12700367","journal-title":"Pediatr Res"},{"issue":"5","key":"1728_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1203\/00006450-200105000-00017","volume":"49","author":"GI Baroncelli","year":"2001","unstructured":"Baroncelli GI, Federico G, Bertelloni S, De Terlizzi F, Cadossi R, Saggese G: Bone quality assessment by quantitative ultrasound of proximal phalanxes of the hand in healthy subjects aged 3\u201321 years. Pediatr Res. 2001, 49 (5): 713-718. PubMed PMID: 11328957","journal-title":"Pediatr Res"},{"issue":"3","key":"1728_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1385\/JCD:3:3:251","volume":"3","author":"CF Njeh","year":"2000","unstructured":"Njeh CF, Shaw N, Gardner-Medwin JM, Boivin CM, Southwood TR: Use of quantitative ultrasound to assess bone status in children with juvenile idiopathic arthritis: a pilot study. J Clin Densitom. 2000, 3 (3): 251-260. PubMed PMID: 11090232","journal-title":"J Clin Densitom"},{"issue":"Suppl 1","key":"1728_CR32","first-page":"S23","volume":"8","author":"H Fleisch","year":"1987","unstructured":"Fleisch H: Bisphosphonates\u2013history and experimental basis. Bone. 1987, 8 (Suppl 1): S23-S28. PubMed PMID: 3318890","journal-title":"Bone"},{"issue":"3","key":"1728_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00467-004-1790-8","volume":"20","author":"PD Acott","year":"2005","unstructured":"Acott PD, Wong JA, Lang BA, Crocker JF: Pamidronate treatment of pediatric fracture patients on chronic steroid therapy. Pediatr Nephrol. 2005, 20 (3): 368-373. PubMed PMID: 15690187","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"1728_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03349860","volume":"19","author":"F Falcini","year":"1996","unstructured":"Falcini F, Trapani S, Civinini R, Capone A, Ermini M, Bartolozzi G: The primary role of steroids on the osteoporosis in juvenile rheumatoid patients evaluated by dual energy X-ray absorptiometry. J Endocrinol Invest. 1996, 19 (3): 165-169. PubMed PMID: 8743282","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1728_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1515\/JPEM.2003.16.4.529","volume":"16","author":"A Noguera","year":"2003","unstructured":"Noguera A, Ros JB, Pavia C, Alcover E, Valls C, Villaronga M, Gonz\u00e1lez E: Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. J Pediatr Endocrinol Metab. 2003, 16 (4): 529-536. PubMed PMID: 12793604","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"1728_CR36","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1515\/JPEM.2003.16.6.887","volume":"16","author":"LM Gandrud","year":"2003","unstructured":"Gandrud LM, Cheung JC, Daniels MW, Bachrach LK: Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis. J Pediatr Endocrinol Metab. 2003, 16 (6): 887-892. PubMed PMID: 12948302","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"1728_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/00005792-199707000-00005","volume":"76","author":"C Brumsen","year":"1997","unstructured":"Brumsen C, Hamdy NA, Papapoulos SE: Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine. 1997, 76 (4): 266-283. PubMed PMID: 9279333","journal-title":"Medicine"},{"issue":"2","key":"1728_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/adc.83.2.143","volume":"83","author":"NJ Shaw","year":"2000","unstructured":"Shaw NJ, Boivin CM, Crabtree NJ: Intravenous pamidronate in juvenile osteoporosis. Arch Dis Child. 2000, 83 (2): 143-145. PubMed PMID: 10906023. Pubmed Central PMCID: 1718443","journal-title":"Arch Dis Child"},{"issue":"3","key":"1728_CR39","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1210\/jc.2002-021371","volume":"88","author":"F Rauch","year":"2003","unstructured":"Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH: Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab. 2003, 88 (3): 986-992. PubMed PMID: 12629073","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1728_CR40","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/adc.87.6.562-a","volume":"87","author":"I Banerjee","year":"2002","unstructured":"Banerjee I, Shortland GJ, Evans WD, Gregory JW: Osteogenesis imperfecta and intravenous pamidronate. Arch Dis Child. 2002, 87 (6): 562-563. PubMed PMID: 12456578. Pubmed Central PMCID: 1755843","journal-title":"Arch Dis Child"},{"issue":"5","key":"1728_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S1297-319X(02)00434-7","volume":"69","author":"F Giraud","year":"2002","unstructured":"Giraud F, Meunier PJ: Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients. Joint Bone Spine. 2002, 69 (5): 486-490.","journal-title":"Joint Bone Spine"},{"issue":"12","key":"1728_CR42","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s00256-004-0804-8","volume":"33","author":"JL Fernandes","year":"2004","unstructured":"Fernandes JL, Viana SL, Rocha AL, Ribeiro MC, Castro LC: Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases. Skeletal Radiol. 2004, 33 (12): 732-736. PubMed PMID: 15309334","journal-title":"Skeletal Radiol"},{"issue":"7","key":"1728_CR43","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2106\/JBJS.F.00726","volume":"89","author":"M Al Muderis","year":"2007","unstructured":"Al Muderis M, Azzopardi T, Cundy P: Zebra lines of pamidronate therapy in children. J Bone Joint Surg Am. 2007, 89 (7): 1511-1516. PubMed PMID: 17606790","journal-title":"J Bone Joint Surg Am"},{"issue":"11","key":"1728_CR44","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1515\/JPEM.2004.17.11.1511","volume":"17","author":"M Zacharin","year":"2004","unstructured":"Zacharin M, Kanumakala S: Pamidronate treatment of less severe forms of osteogenesis imperfecta in children. J Pediatr Endocrinol Metab. 2004, 17 (11): 1511-1517. PubMed PMID: 15570988","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"1728_CR45","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s004310100844","volume":"160","author":"YS Lee","year":"2001","unstructured":"Lee YS, Low SL, Lim LA, Loke KY: Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta. Eur J Pediatr. 2001, 160 (11): 641-644. PubMed PMID: 11760017","journal-title":"Eur J Pediatr"},{"issue":"4","key":"1728_CR46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0022-3476(97)70074-X","volume":"131","author":"B Bembi","year":"1997","unstructured":"Bembi B, Parma A, Bottega M, Ceschel S, Zanatta M, Martini C, Ciana G: Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr. 1997, 131 (4): 622-625. PubMed PMID: 9386671","journal-title":"J Pediatr"},{"issue":"6","key":"1728_CR47","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1365-2265.2008.03189.x","volume":"68","author":"JJ Brown","year":"2008","unstructured":"Brown JJ, Ramalingam L, Zacharin MR: Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?. Clin Endocrinol (Oxf). 2008, 68 (6): 863-867. PubMed PMID: 18221397","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"1728_CR48","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S1701-2163(16)34026-9","volume":"30","author":"N Djokanovic","year":"2008","unstructured":"Djokanovic N, Klieger-Grossmann C, Koren G: Does treatment with bisphosphonates endanger the human pregnancy?. J Obstet Gynaecol Can. 2008, 30 (12): 1146-1148. PubMed PMID: 19175968","journal-title":"J Obstet Gynaecol Can"},{"issue":"5","key":"1728_CR49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0022-3476(05)80030-7","volume":"118","author":"T Nishioka","year":"1991","unstructured":"Nishioka T, Kurayama H, Yasuda T, Udagawa J, Matsumura C, Niimi H: Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis. J Pediatr. 1991, 118 (5): 703-707. PubMed PMID: 2019923","journal-title":"J Pediatr"},{"issue":"1","key":"1728_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00223-001-0008-3","volume":"69","author":"A Siamopoulou","year":"2001","unstructured":"Siamopoulou A, Challa A, Kapoglou P, Cholevas V, Mavridis AK, Lapatsanis PD: Effects of intranasal salmon calcitonin in juvenile idiopathic arthritis: an observational study. Calcif Tissue Int. 2001, 69 (1): 25-30. PubMed PMID: 11685430","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1728_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00198-011-1676-0","volume":"23","author":"JA Knopp-Sihota","year":"2012","unstructured":"Knopp-Sihota JA, Newburn-Cook CV, Homik J, Cummings GG, Voaklander D: Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis. Osteoporos Int. 2012, 23 (1): 17-38. PubMed PMID: 21660557","journal-title":"Osteoporos Int"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-12-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T10:55:01Z","timestamp":1716980101000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/1546-0096-12-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1728"],"URL":"https:\/\/doi.org\/10.1186\/1546-0096-12-24","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,9]]},"assertion":[{"value":"25 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}